Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 197,078 | 124,968 | 230,784 | 85,262 | 284,309 |
| Marketable Securities | 244,035 | 406,752 | 135,563 | 257,007 | N/A |
| Receivables | 26,735 | 13,876 | N/A | N/A | N/A |
| Inventories | 6,326 | 3,321 | N/A | N/A | N/A |
| TOTAL | $485,099 | $562,330 | $375,274 | $347,874 | $289,368 |
| Non-Current Assets | |||||
| PPE Net | 2,136 | 2,285 | 208 | 20 | 57 |
| Intangibles | 18,020 | 15,630 | 0 | 0 | 0 |
| Other Non-Current Assets | 2,572 | 2,543 | 566 | 1,168 | 396 |
| TOTAL | $22,728 | $20,458 | $774 | $1,188 | $453 |
| Total Assets | $507,827 | $582,788 | $376,048 | $349,062 | $289,821 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,733 | 3,262 | 2,576 | 260 | 1,744 |
| Accrued Expenses | 54,615 | 68,625 | 26,524 | 15,950 | 6,709 |
| TOTAL | $60,522 | $73,451 | $29,508 | $16,615 | $8,657 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 2,000 | 1,554 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,103 | 3,353 | 0 | 408 | 2,125 |
| TOTAL | $6,143 | $6,586 | $N/A | $408 | $16 |
| Total Liabilities | $66,665 | $80,037 | $29,508 | $17,023 | $8,673 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 103,298 | 101,355 | 87,385 | 73,587 | 61,952 |
| Common Shares | 10 | 10 | 9 | 7 | 6 |
| Retained earnings | -661,403 | -554,081 | -458,585 | -269,668 | -127,487 |
| Other shareholders' equity | 65 | 84 | 9 | -71 | 0 |
| TOTAL | $441,162 | $502,751 | $346,540 | $332,039 | $281,148 |
| Total Liabilities And Equity | $507,827 | $582,788 | $376,048 | $349,062 | $289,821 |